{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T04:55:08Z","timestamp":1791348908670,"version":"4.3.1"},"reference-count":57,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"NIH\/NINDS"},{"DOI":"10.13039\/100006920","name":"University of Pennsylvania","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100006920","id-type":"DOI","asserted-by":"crossref"}]},{"name":"NIH\/NIGMS"},{"name":"US\u2013Israel Binational Science Foundation"},{"name":"Center of Absorption in Science"},{"name":"Ministry of Immigration Absorption"},{"DOI":"10.13039\/501100006245","name":"Ministry of Science and Technology, Israel","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006245","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Schulich"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1016\/j.ymgme.2011.10.005","type":"journal-article","created":{"date-parts":[[2011,10,21]],"date-time":"2011-10-21T00:48:43Z","timestamp":1319158123000},"page":"116-125","source":"Crossref","is-referenced-by-count":69,"title":["The designer aminoglycoside NB84 significantly reduces glycosaminoglycan accumulation associated with MPS I-H in the Idua-W392X mouse"],"prefix":"10.1016","volume":"105","author":[{"given":"Dan","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valery","family":"Belakhov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeyakumar","family":"Kandasamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timor","family":"Baasov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su-Chen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Teh","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Bedwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim M.","family":"Keeling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2011.10.005_bb0005","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1002\/wrna.95","article-title":"Suppression of nonsense mutations as a therapeutic approach to treat genetic diseases","volume":"2","author":"Keeling","year":"2011","journal-title":"WIREs RNA"},{"key":"10.1016\/j.ymgme.2011.10.005_bb0010","series-title":"Recoding: Expansion of Decoding Rules Enriches Gene Expression","article-title":"Recoding therapies for genetic diseases","author":"Keeling","year":"2010"},{"key":"10.1016\/j.ymgme.2011.10.005_bb0015","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.tig.2008.08.010","article-title":"Introducing sense into nonsense in treatments of human genetic diseases","volume":"24","author":"Linde","year":"2008","journal-title":"Trends Genet."},{"key":"10.1016\/j.ymgme.2011.10.005_bb0020","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1084\/jem.20081940","article-title":"Nonaminoglycoside compounds induce readthrough of nonsense mutations","volume":"206","author":"Du","year":"2009","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ymgme.2011.10.005_bb0025","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/nature05756","article-title":"PTC124 targets genetic disorders caused by nonsense mutations","volume":"447","author":"Welch","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.ymgme.2011.10.005_bb0030","doi-asserted-by":"crossref","first-page":"6885","DOI":"10.1074\/jbc.M806728200","article-title":"Poly-l-aspartic acid enhances and prolongs gentamicin-mediated suppression of the CFTR-G542X mutation in a cystic fibrosis mouse model","volume":"284","author":"Du","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2011.10.005_bb0035","doi-asserted-by":"crossref","first-page":"3735","DOI":"10.1016\/j.bmc.2010.03.060","article-title":"Repairing faulty genes by aminoglycosides: development of new derivatives of geneticin (G418) with enhanced suppression of diseases-causing nonsense mutations","volume":"18","author":"Nudelman","year":"2010","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ymgme.2011.10.005_bb0040","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1021\/jm801640k","article-title":"Development of novel aminoglycoside (NB54) with reduced toxicity and enhanced suppression of disease-causing premature stop mutations","volume":"52","author":"Nudelman","year":"2009","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ymgme.2011.10.005_bb0045","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.bbamcr.2008.12.001","article-title":"Lysosomal disorders: from storage to cellular damage","volume":"1793","author":"Ballabio","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ymgme.2011.10.005_bb0050","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1038\/nrm1423","article-title":"The cell biology of lysosomal storage disorders","volume":"5","author":"Futerman","year":"2004","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ymgme.2011.10.005_bb0290","series-title":"The Online Metabolic & Molecular Bases of Inherited Disease","first-page":"3421","article-title":"The mucopolysaccharidoses","author":"Neufeld","year":"2001"},{"key":"10.1016\/j.ymgme.2011.10.005_bb0060","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s10545-008-1040-5","article-title":"Pathogenic cascades in lysosomal disease\u2014why so complex?","volume":"32","author":"Walkley","year":"2009","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2011.10.005_bb0065","first-page":"787","article-title":"Immunoquantification and enzyme kinetics of alpha-l-iduronidase in cultured fibroblasts from normal controls and mucopolysaccharidosis type I patients","volume":"50","author":"Ashton","year":"1992","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ymgme.2011.10.005_bb0070","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0925-4439(98)00046-5","article-title":"Genotype\u2013phenotype correlations in mucopolysaccharidosis type I using enzyme kinetics, immunoquantification and in vitro turnover studies","volume":"1407","author":"Bunge","year":"1998","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ymgme.2011.10.005_bb0075","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1093\/hmg\/10.3.291","article-title":"Gentamicin-mediated suppression of Hurler syndrome stop mutations restores a low level of alpha-l-iduronidase activity and reduces lysosomal glycosaminoglycan accumulation","volume":"10","author":"Keeling","year":"2001","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymgme.2011.10.005_bb0080","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ymgme.2009.08.002","article-title":"Characterization of an MPS I-H knock-in mouse that carries a nonsense mutation analogous to the human IDUA-W402X mutation","volume":"99","author":"Wang","year":"2010","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2011.10.005_bb0085","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1093\/hmg\/6.4.503","article-title":"Murine mucopolysaccharidosis type I: targeted disruption of the murine alpha-l-iduronidase gene","volume":"6","author":"Clarke","year":"1997","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymgme.2011.10.005_bb0090","first-page":"479","article-title":"A dual-luciferase reporter system for studying recoding signals","volume":"4","author":"Grentzmann","year":"1998","journal-title":"RNA"},{"key":"10.1016\/j.ymgme.2011.10.005_bb0095","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1006\/abio.2000.4829","article-title":"Diphenylamine\u2013aniline\u2013phosphoric acid reagent, a versatile spray reagent for revealing glycoconjugates on thin-layer chromatography plates","volume":"287","author":"Anderson","year":"2000","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.ymgme.2011.10.005_bb0100","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/nar\/22.1.15","article-title":"On the relationship between preferred termination codon contexts and nonsense suppression in human cells","volume":"22","author":"Martin","year":"1994","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ymgme.2011.10.005_bb0105","doi-asserted-by":"crossref","first-page":"6593","DOI":"10.1128\/MCB.15.12.6593","article-title":"Context effects on misreading and suppression at UAG codons in human cells","volume":"15","author":"Phillips-Jones","year":"1995","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.ymgme.2011.10.005_bb0110","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1017\/S1355838200000716","article-title":"Aminoglycoside antibiotics mediate context-dependent suppression of termination codons in a mammalian translation system","volume":"6","author":"Manuvakhova","year":"2000","journal-title":"RNA"},{"key":"10.1016\/j.ymgme.2011.10.005_bb0115","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1471-2199-2-3","article-title":"UAG readthrough in mammalian cells: effect of upstream and downstream stop codon contexts reveal different signals","volume":"2","author":"Cassan","year":"2001","journal-title":"BMC Mol. Biol."},{"key":"10.1016\/j.ymgme.2011.10.005_bb0120","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1002\/ana.20052","article-title":"Readthrough of dystrophin stop codon mutations induced by aminoglycosides","volume":"55","author":"Howard","year":"2004","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ymgme.2011.10.005_bb0125","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/1531-8249(200008)48:2<164::AID-ANA5>3.0.CO;2-B","article-title":"Sequence specificity of aminoglycoside-induced stop codon readthrough: potential implications for treatment of Duchenne muscular dystrophy","volume":"48","author":"Howard","year":"2000","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ymgme.2011.10.005_bb0130","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.semcdb.2004.03.002","article-title":"Secondary accumulation of gangliosides in lysosomal storage disorders","volume":"15","author":"Walkley","year":"2004","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.ymgme.2011.10.005_bb0135","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/j.1399-0004.1998.tb02745.x","article-title":"Murine MPS I: insights into the pathogenesis of Hurler syndrome","volume":"53","author":"Russell","year":"1998","journal-title":"Clin. Genet."},{"key":"10.1016\/j.ymgme.2011.10.005_bb0140","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1093\/oxfordjournals.jbchem.a133753","article-title":"The occurrence of GM4 and GM2 in erythrocytes from inbred strains of mice","volume":"91","author":"Hashimoto","year":"1982","journal-title":"J. Biochem."},{"key":"10.1016\/j.ymgme.2011.10.005_bb0145","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1093\/oxfordjournals.jbchem.a126284","article-title":"The chemistry of the lipids of posthemolytic residue or stroma of erythrocytes II. On the structure of hemataminic acid","volume":"39","author":"Yamakawa","year":"1951","journal-title":"J. Biochem."},{"key":"10.1016\/j.ymgme.2011.10.005_bb0150","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1006\/jmbi.1996.0526","article-title":"RNA sequence determinants for aminoglycoside binding to an A-site rRNA model oligonucleotide","volume":"262","author":"Recht","year":"1996","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.ymgme.2011.10.005_bb0295","doi-asserted-by":"crossref","first-page":"7716","DOI":"10.1021\/bi973125y","article-title":"rRNA chemical groups required for aminoglycoside binding","volume":"37","author":"Blanchard","year":"1998","journal-title":"Biochemistry (Mosc.)"},{"key":"10.1016\/j.ymgme.2011.10.005_bb0160","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1006\/jmbi.2000.4420","article-title":"Structural origins of aminoglycoside specificity for prokaryotic ribosomes","volume":"306","author":"Lynch","year":"2001","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.ymgme.2011.10.005_bb0165","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1006\/jmbi.2000.4419","article-title":"Structure of a eukaryotic decoding region A-site RNA","volume":"306","author":"Lynch","year":"2001","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.ymgme.2011.10.005_bb0170","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1261\/rna.805208","article-title":"Eukaryotic ribosomal RNA determinants of aminoglycoside resistance and their role in translational fidelity","volume":"14","author":"Fan-Minogue","year":"2007","journal-title":"RNA"},{"key":"10.1016\/j.ymgme.2011.10.005_bb0175","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2133\/dmpk.19.159","article-title":"Molecular aspects of renal handling of aminoglycosides and strategies for preventing the nephrotoxicity","volume":"19","author":"Nagai","year":"2004","journal-title":"Drug Metab. Pharmacokinet."},{"key":"10.1016\/j.ymgme.2011.10.005_bb0180","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1128\/AAC.43.5.1003","article-title":"Aminoglycosides: nephrotoxicity","volume":"43","author":"Mingeot-Leclercq","year":"1999","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ymgme.2011.10.005_bb0185","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ymthe.2003.11.020","article-title":"Antioxidant gene therapy can protect hearing and hair cells from ototoxicity","volume":"9","author":"Kawamoto","year":"2004","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymgme.2011.10.005_bb0190","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S0378-5955(00)00003-4","article-title":"Antioxidants attenuate gentamicin-induced free radical formation in vitro and ototoxicity in vivo: d-methionine is a potential protectant","volume":"142","author":"Sha","year":"2000","journal-title":"Hear. Res."},{"key":"10.1016\/j.ymgme.2011.10.005_bb0195","doi-asserted-by":"crossref","first-page":"20888","DOI":"10.1073\/pnas.0811258106","article-title":"Genetic analysis of interactions with eukaryotic rRNA identify the mitoribosome as target in aminoglycoside ototoxicity","volume":"105","author":"Hobbie","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ymgme.2011.10.005_bb0200","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0076-6879(10)78021-6","article-title":"Aminoglycosides redesign strategies for improved antibiotics and compounds for treatment of human genetic diseases","volume":"478","author":"Pokrovskaya","year":"2010","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.ymgme.2011.10.005_bb0205","doi-asserted-by":"crossref","first-page":"6310","DOI":"10.1016\/j.bmcl.2006.09.013","article-title":"Redesign of aminoglycosides for treatment of human genetic diseases caused by premature stop mutations","volume":"16","author":"Nudelman","year":"2006","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ymgme.2011.10.005_bb0210","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s00109-001-0317-z","article-title":"Clinically relevant aminoglycosides can suppress disease-associated premature stop mutations in the IDUA and P53 cDNAs in a mammalian translation system","volume":"80","author":"Keeling","year":"2002","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.ymgme.2011.10.005_bb0215","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.bbmt.2008.01.009","article-title":"The clinical outcome of Hurler syndrome after stem cell transplantation","volume":"14","author":"Aldenhoven","year":"2008","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.ymgme.2011.10.005_bb0220","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/00062752-199911000-00004","article-title":"Bone marrow transplantation for globoid cell leukodystrophy, adrenoleukodystrophy, metachromatic leukodystrophy, and Hurler syndrome","volume":"6","author":"Krivit","year":"1999","journal-title":"Curr. Opin. Hematol."},{"key":"10.1016\/j.ymgme.2011.10.005_bb0225","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00063030-200519010-00001","article-title":"Laronidase treatment of mucopolysaccharidosis I","volume":"19","author":"Wraith","year":"2005","journal-title":"BioDrugs"},{"key":"10.1016\/j.ymgme.2011.10.005_bb0230","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1042\/BST0380695","article-title":"Genistein: a natural isoflavone with a potential for treatment of genetic diseases","volume":"38","author":"Wegrzyn","year":"2010","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.ymgme.2011.10.005_bb0300","doi-asserted-by":"crossref","first-page":"CR196","DOI":"10.12659\/MSM.881715","article-title":"Two-year follow-up of Sanfilippo Disease patients treated with a genistein-rich isoflavone extract: assessment of effects on cognitive functions and general status of patients","volume":"17","author":"Piotrowska","year":"2011","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.ymgme.2011.10.005_bb0240","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1093\/hmg\/3.6.861","article-title":"Mucopolysaccharidosis type I: identification of 8 novel mutations and determination of the frequency of the two common alpha-l-iduronidase mutations (W402X and Q70X) among European patients","volume":"3","author":"Bunge","year":"1994","journal-title":"Hum. Mol. Genet."},{"issue":"Suppl. 124","key":"10.1016\/j.ymgme.2011.10.005_bb0305","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1093\/infdis\/124.Supplement_1.S214","article-title":"Pharmacologic evaluation of gentamicin in newborn infants","volume":"124","author":"McCracken","year":"1971","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ymgme.2011.10.005_bb0250","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1136\/bmj.2.5551.539","article-title":"Intrathecal gentamicin in treatment of ventriculitis in children","volume":"2","author":"Newman","year":"1967","journal-title":"Br. Med. J."},{"key":"10.1016\/j.ymgme.2011.10.005_bb0255","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1111\/j.1476-5381.2009.00565.x","article-title":"Genistein reduces glycosaminoglycan levels in a mouse model of mucopolysaccharidosis type II","volume":"159","author":"Friso","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ymgme.2011.10.005_bb0260","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/nrm778","article-title":"Megalin and cubilin: multifunctional endocytic receptors","volume":"3","author":"Christensen","year":"2002","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ymgme.2011.10.005_bb0265","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1128\/AAC.24.2.147","article-title":"Effect of osmotic blood\u2013brain barrier disruption on gentamicin penetration into the cerebrospinal fluid and brains of normal rabbits","volume":"24","author":"Strausbaugh","year":"1983","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ymgme.2011.10.005_bb0270","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1128\/AAC.32.7.1034","article-title":"Gentamicin penetration into cerebrospinal fluid in experimental Haemophilus influenzae meningitis","volume":"32","author":"Smith","year":"1988","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ymgme.2011.10.005_bb0275","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s00109-010-0704-4","article-title":"Readthrough of nonsense mutations in Rett syndrome: evaluation of novel aminoglycosides and generation of a new mouse model","volume":"89","author":"Brendel","year":"2010","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.ymgme.2011.10.005_bb0280","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1128\/AAC.35.12.2591","article-title":"Long-term protection of polyaspartic acid in experimental gentamicin nephrotoxicity","volume":"35","author":"Swan","year":"1991","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ymgme.2011.10.005_bb0285","doi-asserted-by":"crossref","first-page":"R54","DOI":"10.1093\/hmg\/ddr112","article-title":"Combination therapies for lysosomal storage disease: is the whole greater than the sum of its parts?","volume":"20","author":"Hawkins-Salsbury","year":"2011","journal-title":"Hum. Mol. Genet."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S109671921100374X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S109671921100374X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,18]],"date-time":"2019-06-18T08:17:13Z","timestamp":1560845833000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S109671921100374X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":57,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["S109671921100374X"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2011.10.005","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1]]}}}